AU3452297A – Treatment and diagnosis of infections of gram positive cocci
– Google Patents
AU3452297A – Treatment and diagnosis of infections of gram positive cocci
– Google Patents
Treatment and diagnosis of infections of gram positive cocci
Info
Publication number
AU3452297A
AU3452297A
AU34522/97A
AU3452297A
AU3452297A
AU 3452297 A
AU3452297 A
AU 3452297A
AU 34522/97 A
AU34522/97 A
AU 34522/97A
AU 3452297 A
AU3452297 A
AU 3452297A
AU 3452297 A
AU3452297 A
AU 3452297A
Authority
AU
Australia
Prior art keywords
diagnosis
methods
treatment
gram positive
same
Prior art date
1996-07-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU34522/97A
Other versions
AU717332B2
(en
Inventor
James Peter Burnie
Ruth Christine Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neutec Pharma Ltd
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1996-07-06
Filing date
1997-07-07
Publication date
1998-02-02
1997-07-07
Application filed by Neutec Pharma Ltd
filed
Critical
Neutec Pharma Ltd
1998-02-02
Publication of AU3452297A
publication
Critical
patent/AU3452297A/en
2000-03-23
Application granted
granted
Critical
2000-03-23
Publication of AU717332B2
publication
Critical
patent/AU717332B2/en
2017-07-07
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/04—Antibacterial agents
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
Abstract
The present invention provides bacterial and fungal ABC transporter proteins, immunogenic fragments thereof, neutralising agents specific thereto and binding agents specific thereto for therapeutic and diagnostic use, together with diagnostic test methods, methods of same and kits for performing same. Also provided are immunodominant conserved antigens from gram positive staphylococci, together with neutralising and binding agents specific thereto for use in therapy and diagnosis, and methods of same. Also provided are Staphylococcal holomogues of IstA and IstB and immunogenic fragments thereof, and their uses in methods of treatment and diagnosis of the human or animal body.
AU34522/97A
1996-07-06
1997-07-07
Treatment and diagnosis of infections of gram positive cocci
Ceased
AU717332B2
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
GBGB9614274.0A
GB9614274D0
(en)
1996-07-06
1996-07-06
Treatment and diagnosis of infections of gram positive cocci
GB9614274
1996-07-06
PCT/GB1997/001830
WO1998001154A2
(en)
1996-07-06
1997-07-07
Treatment and diagnosis of infections of gram positive cocci
Publications (2)
Publication Number
Publication Date
AU3452297A
true
AU3452297A
(en)
1998-02-02
AU717332B2
AU717332B2
(en)
2000-03-23
Family
ID=10796521
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU34522/97A
Ceased
AU717332B2
(en)
1996-07-06
1997-07-07
Treatment and diagnosis of infections of gram positive cocci
Country Status (13)
Country
Link
US
(2)
US6544516B1
(en)
EP
(1)
EP0917471B1
(en)
JP
(1)
JP2001505534A
(en)
AT
(1)
ATE293456T1
(en)
AU
(1)
AU717332B2
(en)
CA
(1)
CA2259141C
(en)
DE
(1)
DE69733067T2
(en)
DK
(1)
DK0917471T3
(en)
ES
(1)
ES2238080T3
(en)
GB
(1)
GB9614274D0
(en)
NZ
(1)
NZ332991A
(en)
PT
(1)
PT917471E
(en)
WO
(1)
WO1998001154A2
(en)
Families Citing this family (9)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US6610293B1
(en)
*
1997-06-16
2003-08-26
The Henry M. Jackson Foundation For The Advancement Of Military Medicine
Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
GB9806762D0
(en)
*
1998-03-31
1998-05-27
Neutec Pharma Plc
Treatment and diagnosis of staphylococcal infections
EP1624064A3
(en)
*
1998-07-27
2006-05-10
Microbial Technics Limited
Nucleic acids and proteins from streptococcus pneumoniae
WO2002057406A2
(en)
*
2001-01-17
2002-07-25
Avestha Gengraine Technologies Pvt Ltd
Dna sequencing of abc transporter or multi drug resistant protein for better environment stress tolerant crops
US6790448B2
(en)
*
2001-05-08
2004-09-14
The Texas A&M University System University
Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them
GB0127983D0
(en)
*
2001-11-22
2002-01-16
Neutec Pharma Plc
Treatment of micro-organism infection
US8729013B2
(en)
2004-08-26
2014-05-20
The University Of Western Ontario
Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
EP2450053B1
(en)
*
2010-11-05
2016-06-15
Universitätsklinikum Freiburg
Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis
CA2879272A1
(en)
2012-07-16
2014-01-23
Robert G.K. DONALD
Saccharides and uses thereof
Family Cites Families (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5747239A
(en)
*
1990-02-16
1998-05-05
United Biomedical, Inc.
Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
JP3219409B2
(en)
*
1991-09-16
2001-10-15
アボツト・ラボラトリーズ
Hepatitis C assay
GB9401689D0
(en)
1994-01-28
1994-03-23
Univ Manchester
Diagnosis and treatment of endocarditis
1996
1996-07-06
GB
GBGB9614274.0A
patent/GB9614274D0/en
active
Pending
1997
1997-07-07
WO
PCT/GB1997/001830
patent/WO1998001154A2/en
active
IP Right Grant
1997-07-07
DE
DE69733067T
patent/DE69733067T2/en
not_active
Expired – Lifetime
1997-07-07
AU
AU34522/97A
patent/AU717332B2/en
not_active
Ceased
1997-07-07
DK
DK97930642T
patent/DK0917471T3/en
active
1997-07-07
PT
PT97930642T
patent/PT917471E/en
unknown
1997-07-07
ES
ES97930642T
patent/ES2238080T3/en
not_active
Expired – Lifetime
1997-07-07
CA
CA002259141A
patent/CA2259141C/en
not_active
Expired – Fee Related
1997-07-07
JP
JP50494298A
patent/JP2001505534A/en
not_active
Ceased
1997-07-07
AT
AT97930642T
patent/ATE293456T1/en
not_active
IP Right Cessation
1997-07-07
EP
EP97930642A
patent/EP0917471B1/en
not_active
Expired – Lifetime
1997-07-07
NZ
NZ332991A
patent/NZ332991A/en
not_active
IP Right Cessation
1997-07-07
US
US09/214,307
patent/US6544516B1/en
not_active
Expired – Fee Related
2002
2002-01-25
US
US10/054,968
patent/US6881410B2/en
not_active
Expired – Fee Related
Also Published As
Publication number
Publication date
DE69733067T2
(en)
2006-01-26
EP0917471B1
(en)
2005-04-20
PT917471E
(en)
2005-07-29
WO1998001154A2
(en)
1998-01-15
US20030119101A1
(en)
2003-06-26
GB9614274D0
(en)
1996-09-04
EP0917471A2
(en)
1999-05-26
AU717332B2
(en)
2000-03-23
WO1998001154A3
(en)
1998-06-25
ES2238080T3
(en)
2005-08-16
CA2259141A1
(en)
1998-01-15
CA2259141C
(en)
2007-12-11
DE69733067D1
(en)
2005-05-25
US6544516B1
(en)
2003-04-08
NZ332991A
(en)
1999-06-29
ATE293456T1
(en)
2005-05-15
JP2001505534A
(en)
2001-04-24
US6881410B2
(en)
2005-04-19
DK0917471T3
(en)
2005-06-06
Similar Documents
Publication
Publication Date
Title
TR200200633T2
(en)
2002-06-21
New streptococcus antigens
WO1999051748A3
(en)
2000-02-03
Fusion proteins of mycobacterium tuberculosis antigens and their uses
WO1998026747A3
(en)
1998-09-17
Superantigen based methods and compositions for treatment of diseases
AP2000001886A0
(en)
2000-09-30
Group B streptococcus antigens.
WO2001098334A3
(en)
2002-09-06
Streptococcus antigens
WO2003039462A3
(en)
2004-08-05
B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
EP1194164B8
(en)
2007-03-21
Prion protein peptides and uses thereof
NZ514887A
(en)
2003-06-30
IBD-associated microbial antigens and methods of using same
GR3035440T3
(en)
2001-05-31
Therapeutic uses of bpi protein products for human meningococcemia
WO1996040940A3
(en)
1997-01-23
A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
AU3452297A
(en)
1998-02-02
Treatment and diagnosis of infections of gram positive cocci
WO2003065973A3
(en)
2004-04-29
Multivalent streptococcal vaccine compositions and methods for use
AU5505198A
(en)
1998-07-17
Methods for diagnosis of allergic bronchopulmonary aspergillosis
AU9363398A
(en)
1999-04-27
Hepatitis c receptor protein cd81
DE69714451D1
(en)
2002-09-05
PRION-BINDING PROTEINS AND THEIR USE
EP0869801A4
(en)
2001-01-17
Therapeutic and diagnostic agents for the treatment of microbial infections
WO2004003155A3
(en)
2004-06-17
Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
AU2579995A
(en)
1996-01-04
Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
IL159479A
(en)
2010-12-30
Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
WO2002058728A3
(en)
2002-10-03
Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
WO2007118077A3
(en)
2008-07-31
Mycobacterial catalase-peroxidase in the diagnosis and treatment of sarcoidosis
WO2002045657A3
(en)
2004-04-08
Ovarian tumor antigen and methods of use therefor
WO2004113386A3
(en)
2005-10-06
Modified hirudin proteins and t-cell epitopes in hirudin
WO2001021653A3
(en)
2001-12-06
Ovarian tumor antigen and methods of use therefor
EP1849800A3
(en)
2007-12-05
Moraxella catarrhalis proteins
Legal Events
Date
Code
Title
Description
2000-07-20
FGA
Letters patent sealed or granted (standard patent)
